Aquilo Capital Management, LLC Galapagos Nv Transaction History

Aquilo Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $7.43 Million - $9.99 Million	-142,340 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $1.76 Million - $2.13 Million	25,617 Added 21.95%	142,340 $9.81 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $3.56 Million - $5.23 Million	46,734 Added 66.77%	116,723 $9 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $3.63 Million - $5.55 Million	37,455 Added 115.13%	69,989 $6.93 Million
Q3 2020 Nov 16, 2020	SELL	$122.47 - $213.56 $1.43 Million - $2.5 Million	-11,700 Reduced 26.45%	32,534 $4.62 Million
Q1 2020 May 15, 2020	SELL	$143.0 - $274.03 $3.97 Million - $7.6 Million	-27,733 Reduced 38.54%	44,234 $8.67 Million
Q4 2019 Feb 14, 2020	BUY	$146.12 - $215.82 $2.21 Million - $3.26 Million	15,127 Added 26.61%	71,967 $14.9 Million
Q3 2019 Nov 14, 2019	BUY	$130.44 - $187.64 $1.3 Million - $1.88 Million	10,000 Added 21.35%	56,840 $8.68 Million
Q2 2019 Aug 14, 2019	BUY	$111.45 - $128.93 $2.79 Million - $3.22 Million	25,000 Added 114.47%	46,840 $6.04 Million
Q1 2019 May 15, 2019	SELL	$89.61 - $117.78 $1.26 Million - $1.66 Million	-14,080 Reduced 39.2%	21,840 $2.57 Million
Q4 2018 Feb 14, 2019	BUY	$87.81 - $110.65 $403,926 - $508,990	4,600 Added 14.69%	35,920 $3.3 Million
Q3 2018 Nov 14, 2018	SELL	$90.63 - $120.22 $3.15 Million - $4.18 Million	-34,730 Reduced 52.58%	31,320 $3.52 Million
Q2 2018 Aug 14, 2018	BUY	$88.4 - $105.34 $5.84 Million - $6.96 Million	66,050 New	66,050 $6.09 Million

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.77B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Aquilo Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aquilo Capital Management, LLC with notifications on news.